scout

Podcasts

Recent Episodes

Opening dialogue and establishing connections across different oncology camps may enhance the use of integrative modalities and bolster patient outcomes.
Bolstering Outcomes and Building Bridges in Integrative Oncology Care
Experts break down the clinical trial data and regulatory developments that made 2025 a “remarkable year” in kidney and bladder cancer management.
What Were the Key Kidney and Bladder Cancer Advances in 2025?
Jose G. Trevino, II, MD, FACS, emphasized educating patients and physicians alike to help recognize early signs of pancreatic ductal adenocarcinoma.
Advancing Research and Combating Disparities in Pancreatic Cancer Care
Rahul Banerjee, MD, FACP, and Brooke Adams, PharmD, BCOP, discussed the top hematologic oncology abstracts from the 2025 ASH Annual Meeting and Exposition.
What’s New in Hematology/Oncology? Discussing the 2025 ASH Annual Meeting
Distress Screening: Making the Fifth Vital Sign Integral to Oncology Care
Distress Screening: Making the Fifth Vital Sign Integral to Oncology Care
Experts share updated results on investigational hematologic oncology regimens that they presented at the 2025 ASH Meeting.
ASH 2025: Key Discussions in Multiple Myeloma, Lymphoma, and Leukemia
Why Sexual and Gender Minority Care Is an Oncologic Imperative
Why Sexual and Gender Minority Care Is an Oncologic Imperative
Experts highlight considerations for treating patients with oligometastatic kidney cancer, such as differentiating between de novo and recurrent disease.
How to Manage Oligometastatic Kidney Cancer? Insights From IKCS 2025
Experts from Georgia Cancer Center highlight ongoing retrospective studies, translational research, and other initiatives across different cancers.
Evolutions Across NSCLC, Multiple Myeloma, and AML at Georgia Cancer Center
Decision-Making Capacity: The Ethical Core of Patient-Centered Oncology
Decision-Making Capacity: The Ethical Core of Patient-Centered Oncology

All series

Opening dialogue and establishing connections across different oncology camps may enhance the use of integrative modalities and bolster patient outcomes.

Recent Episodes

A panel of oncology pharmacists discusses the role of lifileucel in metastatic melanoma and other considerations for using cellular therapy in solid tumors.

Oncology On the Go With ASTCT Talks

Experts break down the clinical trial data and regulatory developments that made 2025 a “remarkable year” in kidney and bladder cancer management.

ONCOLOGY Decoded

RadOnc on the Run with Brandon Mancini, MD, MBA, FACRO

Prospective data observed with the gemcitabine intravesical system may be superior to prior reports of other therapies in BCG-unresponsive NMIBC.

FDA Approval Alert: The Need-to-Know

Oncology-on-the-Go with Daniel C. McFarland, DO

Oncology-on-the-Go with Daniel C. McFarland, DO